Foghorn Therapeutics Inc.
Nasdaq FHTX · Cambridge, MA
Works in Hematology · Oncology · Ophthalmology
Foghorn Therapeutics Inc. is a clinical trial sponsor based in Cambridge, MA, listed as Nasdaq FHTX. It has 1 active clinical trial with 144 planned participants, in Hematology, Oncology and Ophthalmology. Since 2021 it has completed 0 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq FHTX
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Foghorn Therapeutics Inc
Foghorn Therapeutics Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 144 planned participants, in Hematology, Oncology, Ophthalmology. Since 2021 it has completed 0 trials and stopped 2 early.
Foghorn Therapeutics Inc is based in Cambridge, MA and is listed as Nasdaq FHTX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Foghorn Therapeutics Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-07-10.
Approve Suite is not affiliated with Foghorn Therapeutics Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.